Listen Now

Topics Covered

  • Overview of Acute Myelogenous Leukemia (AML), in the Context of COVID-19
  • Current Treatment Options
  • Transplantation as a Treatment Option for AML
  • New Therapies
  • Clinical Trial Updates
  • How Clinical Trials Increase Your Treatment Options
  • Symptom and Pain Management Tips
  • Important Questions to Ask When Communicating with Your Health Care Team
  • How to Prepare for Telehealth Appointments
  • Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Our Panel of Experts

Farhad Ravandi-Kashani, MD

Janiece and Stephen A. Lasher Professor of Medicine, Chief, Section of Departmental Therapeutics, Department of Leukemia, The University of Texas MD Anderson Cancer Center

Alexander Perl, MD

Associate Professor of Medicine, Leukemia Program, Division of Hematology/Oncology, University of Pennsylvania

Eytan M. Stein, MD

Hematologic Oncologist, Clinical Trialist, Acute Myeloid Leukemia, Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare®

Brochure

You can download the brochure for this workshop(pdf)(71.7 KB)

Workshop Date

This workshop was originally recorded on June 19, 2020.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.